Jeffrey M. Jacobson, MD is Professor of Medicine and Neuroscience and Co-Director, Center of Translational AIDS Research Lewis Katz School of Medicine at Temple University. He has extensive experience in the care and investigative study of HIV-infected patients. His particular focus of research has been on the immunology and immunopathogenesis of HIV-1 infection, including vaccine, gene and other immune-based therapies, as well as monoclonal antibody development. He led early proof-of-concept clinical studies of hyperimmune plasma, neutralizing antibodies, and antibodies that inhibit cell entry by HIV-1.
He has chaired numerous clinical research studies of the pathogenesis, pharmacokinetics, and treatment of HIV-1 infection, and has chaired several AIDS Clinical Trials Group (ACTG) committees, including the Immunology Committee and the Translational Research and Drug Development Committee. He has also co-chaired the Long Acting Drug Task Force in the ACTG, and he hopes his studies of long-acting injectable anti-HIV-1 monoclonal antibodies for the treatment of HIV infection help in the efforts to energize the development of long-acting antiretroviral drug formulations.
Conflict of Interest: I have no real or apparent conflicts of interest to report.